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Abstract 
Magnesium plays key roles in several vital reactions within the body, with the 
roles played in energy production and protein synthesis suggesting a link with 
muscle strength. Magnesium intake is considered sub-optimal in western 
populations with certain individuals possibly being predisposed to 
hypomagnesemia. The determination of magnesium status can be conducted 
through various methodologies with some considered as being more reflective 
than others. Magnesium supplementation can be utilised as a method to correct 
deficiencies, with certain studies suggesting strength augmentations and 
alterations in body composition as a result. The purpose of this article is to review 
some of the suggested physiological roles of magnesium, the various options for 
uncovering whole body status, as well as any possible benefits of 
supplementation. 
Keywords: intake, physiology, whole body status, performance 
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Introduction 
Magnesium (Mg) is a trace mineral and a co-factor for over 300 enzymatic 
reactions, involved in cellular energy production and storage, protein synthesis 
cell-growth and reproduction, maintenance of cellular electrolyte composition and 
stabilisation of mitochondrial membranes (Newhouse & Finstad, 2000). 
Subsequently Mg is involved in numerous body functions including those 
controlling neuromuscular transmission, cardiac excitability and vasomotor tone 
and blood pressure (Altura, 1991). The adult human body contains around 25g 
of Mg, of which; 50-60% is located within hydroxyl-apatite of the bony skeleton, 
whereas the rest can mostly be found within muscles and soft tissues with only 
1% being present in extracellular fluids (Aikawa, 1981). 
 
The term ‘muscle strength’ was introduced as a medical subject heading (MeSH) 
term in the PubMed database in 2007; where it is defined as the amount of force 
generated by muscular contraction (Saey & Toosters, 2008). Muscle strength in 
different populations is considered an indicator of nutritional status and a suitable 
predictor of decreased osteoporotic fracture, disability and mortality in both 
middle-aged and elderly (Rantanen et al., 2000, cited in Moslehi, Vafa, 
Sarrafzadeh and Foroushani, 2013). Furthermore, studies have also related low 
levels of muscle strength with an independently increased risk for metabolic 
syndrome irrespective of age, body size, insulin resistance and central obesity 
(Jurca et al., 2005). Similarly, increased physical activity has been directly 
correlated with increased muscle mass (improved body composition) and muscle 
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strength (Sandler et al., 1991, and Urdiales et al., 2010) and consequently could 
lead to strength and body composition associated benefits. Body composition can 
be divided into 2 compartments; either fat-free mass (FFM) and fat or Lean Body 
Mass (LBM) and lipid. The difference between the 2 classifications is that FFM 
includes essential fat whereas LBM does not. The difference arises due to the 
different ways of measuring body composition where measurement through the 
use of calipers measure FFM and Hydrostatic weighing measures LBM. 
However, Wang, Piersen and Heymsfield (1992) suggested that due to the minor 
contribution of essential fat, the terms FFM and LBM, could be used 
interchangeably. 
 
Magnesium physiology 
Mg homeostasis is tightly regulated by the intestines and kidneys, increasing 
absorption or reabsorption during a deficient period, and increasing excretion 
during periods of excess, while the skeleton acts as an intrinsic storage for the 
mineral to buffer acute changes in extracellular Mg levels (Favus, Bushinsky & 
Lemann, 2006). Of the Mg content of bone (15g), a third (5g) is considered as 
being readily available to act as a buffer for extracellular hypomagnesemia (Alfrey 
& Miller, 1973). 
 
Increased levels of physical activity specifically: sustained moderate exercise 
(Stendig-Lindberg, Shapiro, Tepperberg & Moran, 1999) and short-term high 
intensity exercise (Meludu et al., 2001) result in a mobilisation of Mg towards 
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muscle and adipocytes, leading to a transient decrease in serum magnesium 
(cited in Nielsen & Lukaski, 2006). Synergistically, a study conducted on 13 male 
athletes performing short-term, high-intensity anaerobic exercise (> 90% VO2 
max) uncovered that more than 85% of the transient decrease in plasma Mg during 
exercise could be accounted for by the transient increase in anaerobic 
metabolism (Deuster, Dolev, Kyle, Anderson & Schoomaker, 1987), as observed 
through an increase in blood lactate concentration (r=0.68, p<0.01). Such a 
metabolic shift precipitates into re-mobilisation of Mg to the plasma from bones, 
soft-tissues, muscles and adipocytes, following exercise in order to restore 
plasma pre-exercise Mg levels (Nielsen & Lukaski, 2006). Subsequently, this 
allows plasma Mg to return to pre-exercise values within 120 minutes, however, 
urinary excretion of Mg remains elevated by 21% for 24 hours following exercise.  
 
This observation was also seen in Deuster et al (1987) who uncovered significant 
increases in Mg urinary excretion on the day of exercise (131.5 ± 6.8mg/day) 
when compared to non-exercise days (108 ± 6.6 mg/day). The authors ultimately 
postulated that the percentage contribution of anaerobic metabolism to total 
energy expenditure is positively correlated with the inter-compartmental shift in 
Mg. Ultimately, this is suggestive that while exercise and muscle strength might 
be correlated through Mg, higher exercise levels require higher intakes of Mg in 
order to support the translation into increased muscle strength.  
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In turn, the roles of Mg in oxygen uptake, energy production and electrolyte 
balance, further underline the link between Mg and exercise as Mg deficiency has 
been purported to increase exercise related oxygen requirements, while 
decreasing adenosine tri-phosphate (ATP) production, leading to decreased 
efficiency and an attenuation in exercise performance (Lukaski & Nielsen, 2002). 
 
Alcoholism is recognised as the most common cause of disturbed magnesium 
balance (Galanter, 2013). In fact, increased alcohol intake increases the risk for 
hypomagnesemia through decreasing intestinal Mg absorption while also acutely 
stimulating increasing Mg excretion up to 167 to 260% compared to control 
subjects (Sarai, Tejai, Chan, Kuo, & Li, 2013). Consequently, the increased 
excretion predisposes chronic alcoholics, to have decreased Mg status as 
uncovered by lower muscle Mg levels (Jermain, Drimset, & Drisbet, 1992). 
 
Magnesium status 
Mg status is generally measured through testing for total Mg (TMg) in serum or 
plasma and is considered adequate when TMg ranges between 17-23 µg/ml for 
adults over 17 years of age (Mayo Medical Laboratories, 2015). However, this 
test in isolation is not necessarily reflective of whole body nutriture (Newhouse 
and Finstad, 2000), due to the fact that only 1% of total body magnesium is 
present in the blood of which 0.7% can be found in erythrocytes (EMg) and only 
0.3%, within the serum (Fawcett, Haxby & Male, 1999). Furthermore, serum Mg 
is categorised into three: free/ionised (iMg), bound to proteins, or complexed with 
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anions such as phosphate, bicarbonate, citrate or sulphate (Maguire & Cowan, 
2002). However of all the 3 components within serum, iMg is known to be the 
most bioactive and is consequently considered to be more representative than 
TMg (Altura et al., 1994). Comparatively, TMg and EMg are not seriously 
impacted until severely hypomagnesemic (Altura et al., 1994). This is directly in 
line with; Galanter (2013), who argued that while serum Mg demonstrates 
hypomagnesemia in only 25-50% of alcoholics, Mg retention following parenteral 
Mg administration in alcoholic indicate that the condition is much more prevalent 
and subsequently, the sole utilisation of TMg is not optimally indicative of total 
body Mg status. 
 
However, while testing for iMg might be more indicative, the hemodynamic 
equilibrium aspect of such a component implies accounting for several variables 
in order to obtain representative results (Newhouse, Johnson, Montelpare & 
McAuliffe, 2002). In fact recommendations for the test include conducting it in a 
fasted, non-exercised state, first thing in the morning (Fraser & Harris, 1989).  
However, measuring Mg status through iMg also has its downsides. While iMg 
proved to be more sensitive at reflecting increased Mg intakes through 
supplementation (4 weeks of 212mg/day Mg oxide), iMg status between baseline 
and pre-test also varied significantly resulting in a number of participants of 
previously low status becoming normal (Finstad et al., 2001). The authors 
ultimately postulated that although the variability in iMg status over time could be 
due to increased nutritional status awareness within subjects, the physiological 
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perturbations which could alter iMg status must be researched further to allow the 
assessment, classification and diagnosis of Mg status through this assay.  
 
Other measurements of Mg status include hair analysis. Hair analysis can be 
utilised to measure concentration of trace minerals and it is reflective of mineral 
status over longer time frames, potentially years (Bass, Hickok, Quig & Urek, 
2001). Consequently, the authors of this review concluded that hair analysis 
might be more reflective of long-term trace mineral status in comparison with 
other analytical methods. However, a review of the method uncovered significant 
inter-laboratory variation and concluded that standardisation of testing protocols 
would be paramount to improving inter-laboratory comparability (Seidel, Kreutzer, 
Smith, McNeel & Gilliss, 2001). 
 
Ultimately, Holm and Jespen ((1987) argue that adequate Mg status could be 
verified by Mg loading and a subsequent urinalysis. Consequently, Newhouse 
and Finstad (2000) conclude that in order for the analysis of Mg status to optimally 
reflect whole body Mg status, an iMg test validated by Mg loading and subsequent 
24 hour urinalysis should be undertaken. 
 
Dietary sources and recommended intakes 
Magnesium can be found in a variety of plant and animal sources namely; nuts, 
wholegrains, fish and seafood and also several vegetables, legumes berries and 
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bananas while Recommended Daily Allowances (RDAs) for Mg in adults stand at 
400 and 310 mg/day, respectively, for males and females aged 19-30 years 
(EFSA, 2015). Also, high intakes of alcohol, fibre and calcium (>2600mg/day), 
and low protein intakes (<30g/day) were found to negatively impact Mg 
absorption and retention through phosphate binding, competitive inhibition and 
increased renal excretion, respectively. Additionally poor Mg status was also a 
predictor for hypocalcaemia and hypovitaminosis D (FNB, 2006).  
 
Supplementation 
Mg status can also be effected through supplementation. Oral Mg 
supplementation can be utilised and it is present as several salts and chelates 
including: oxide, chloride and citrate. Following a comparison of different oral 
magnesium supplements for bioavailability, similarly high bioavailabilities were 
uncovered for Mg contained in Mg citrate (50%) and chloride preparations, when 
compared with Mg oxide (4%) (Firoz & Graber, 2001). Additionally, some studies 
state that soluble preparations tend to be better absorbed than capsulated ones 
(Ranande & Somberg, 2001).  
 
However, while oral Mg supplementation is possible, successful remineralisation 
through this method could take a long time depending on the form of Mg utilised 
(Ford, 1999). Contributing factors to this include the absorption physiology of oral 
Mg; being absorbed largely in the small bowel by a combination of passive 
diffusion and saturable active transport mechanisms, suggesting; limited 
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absorption rates and increased risk of adverse effects such as osmotic retention 
in the colon, leading to diarrhoea, as dosages of Mg increase (Graham, Caesar 
& Burgen, 1960, cited in Quamme, 2008). Subsequently, in view of the increased 
risk for possible associated effects of high doses, Tolerable Upper Limits (TULs) 
for supplemental Mg have been established. TULs stand at 350 mg of 
supplemental Mg/day for adults of both genders (Institute of Medicine, 1997). 
  
Alternatively, in view of the many interferences to oral supplementation, topical 
and transdermal supplementation of Mg might be considered, through the 
utilisation of a variety of solutions, creams and bath salts (Nica et al., 2015). The 
authors of a pilot study (9 participants: 2 males, 7 females, aged 22-69 years; 
mean age 48.5 years) utilised a 12 week application of a 31% Mg chloride 
solution through 20 sprays/day and a 20 minute foot soak with 100ml oil twice 
weekly and uncovered an increase in Mg levels between 2-262% (calculated 
through hair analysis) in 8 of 9 participants, one of which stopped the application 
at 2 weeks prior testing (Watkins & Josling, 2010). An average increase of 59.7% 
in Mg levels was observed in this study, and it was compared to the effects of 9-
24 months of oral Mg supplementation in Nica et al. (2015). 
 
Dietary intake 
However, prior to suggesting supplementation, a rigorous assessment regarding 
present intake should be conducted. Almost half (48%) of the US population was 
found to be consuming less than the RDA in 2005-2006 (Rosanoff, Weaver & 
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Rude, 2012). Concomitantly, in an analysis of 24-h dietary recall data of 4257 
participants (age > 20 years) from the National Health and Nutrition Examination 
Survey (1999-2000) in the US, median and mean intakes for all the different 
ethnic groups, were all undistinctively found to be below RDA levels of Mg; with 
the highest mean daily Mg intake being in Caucasian men (352 mg), and the 
lowest mean daily Mg intake in African American men (278 mg) (Ford & Mokdad, 
2003). In the same study, females were also found to be having magnesium 
deficient diets with Caucasian women having mean Mg intakes of 256 mg/day 
and Mg intakes for African American women standing at 202 mg/day. Upon 
analysis of a 7-day food record, populations in other developed countries 
(France), were found to have even lower intakes of Mg with 71.7% of French 
males aged between 15-92 years not meeting daily RDA for Mg (Touvier et al., 
2006).  
 
Additionally with regards to physically active individuals increased excretory 
losses observed following acute bouts of physical activity may be suggestive of 
increased requirements (Buchman et al., 1998). Furthermore, Lukaski (2000) 
reported decreased intakes (< 69%) in athletes participating in certain sports 
including basketball, soccer and gymnastics. Similarly, Santos et al. (2011) 
following an analysis of dietary intakes in 26, male elite volleyball, handball and 
basketball players uncovered that Mg intakes varied between 42-80% of RDA 
(mean ± SD: 244.7 ± 78.8 mg/day) indicating marginal deficiency.  
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Furthermore, given dietary Mg is positively correlated with increased energy 
intake; voluntary food restriction, and certain food choices, coupled with high 
levels of physical activity, as practiced in certain sports, linked with varying 
degrees of aesthetic appearance (such as; gymnastics, dancing, wrestling and 
bodybuilding), could lead to increased risk of low dietary intakes and effectively 
hypomagnesemia (Lukaski, 2000).  
 
Wolinsky 1997 reported Mg intakes for strength athletes specifically: American 
Football players, weightlifters and bodybuilders. Data is available for pre-
competition, competition and post-competition seasons in female bodybuilders 
and for pre-competition and competition season in male bodybuilders (Table 1). 
Bodybuilders achieve low body fat levels for competition through a combination 
of dietary manipulation and increased exercise volumes (Helms, Aragon & 
Fitschen, 2014). Furthermore, Wolinsky (1997) also reported dietary Mg intakes 
for weightlifters at amateur and elite levels. As observed (Table 1) Mg intakes are 
very close to RDA levels for female bodybuilders, especially in competition 
season. The trend of female athletes having close to RDA or lower intakes of has 
been observed even in other sport disciplines and was attributed, at least in part, 
to women having lower overall energy intakes and possibly making different food 
choices (Lukaski, 2000).  
 
Subsequently, given that exercise was uncovered to increase Mg turnover 
(Deuster, 1987), pre-competition Mg intake in female bodybuilders would be 
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considered sub-optimal. The increase in Mg during competition might be 
attributed to an alteration in food choices. In turn, Bazzarre et al. (1993) reported 
that 100% of female athletes use mineral-vitamin supplements compared to only 
51% of male athletes.  
 
Table 1: Summary of dietary Mg intakes in Bodybuilders, Weightlifters and American 
Football Players. 
  Males Females 
  Bodybuilders Bodybuilders 
  Magnesium (mg/day)  Magnesium (mg/day)  
Pre-Competition 631  276  
Competition 569  314  
Post-Competition /  341  
  Weightlifters    
Elite level 777     
Amateur level 374     
  American Football    
  558      
Adapted from: ‘Nutrition and Strength’ by Wolinsky, I., 1997, Nutrition in Exercise and 
Sport (3rd ed.), p. 382-383. 
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Magnesium, strength and body composition 
Dominquez et al. (2006) analysed data from the InCHIANTI study, encompassing 
around 1138 elderly subjects (mean ± SD age: 66.7 ± 15.2 years). The authors 
uncovered that total serum Mg was positively correlated with different measures 
of muscle strength, specifically; grip strength (p = 0.0002), lower-leg muscle 
power (p = 0.0001), knee extension torque (p = 0.0001), and ankle extension 
strength (p = 0.0001). A similar study was conducted by Santos et al (2011) 
analysing the correlation between dietary Mg intake and strength in 26 male 
professional volleyball, basketball and handball players. The authors reported 
significant correlation between daily Mg intake and trunk flexion (p = 0.025), squat 
jump (p = 0.02), counter-movement jump Abalakov (p = 0.012), and peak torque 
measurements for both extension and flexion (p < 0.02). Furthermore, strength 
measurements were still significant following adjustments for energy intakes: 
trunk flexion (p = 0.028), handgrip (p = 0.027), peak torque 180º extension (p < 
0.001) and peak torque 180º flexion (p < 0.001). Also, in a study by Poikolainen and 
Alho (2008), encompassing alcoholics (n = 118, 81 males, 37 females; aged 20-
64 years), the subjects were found to have lower than average strength levels 
(analysed through handgrip strength) in comparison with age-matched reference 
values, published by the Institute for Occupational Health in Finland. 
Subsequently, the decreased strength levels could be directly correlated with the 
limitations presented by low Mg levels, present in this population (Jermain et al., 
1992), and in turn an increase in Mg intake, coupled with a decrease in alcohol 
intake, could assist in reversing decreased muscle Mg levels and strength. 
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Lukaski and Nielsen (2002) conducted a 3 month depletion-repletion Mg study, 
with 312mg/day the first month, to stabilise Mg status, then 112mg/day of Mg the 
second month to deplete Mg, and a repletion with 312mg/day of Mg. Exercise 
included cycling at increasing intensities until 80% max heart rate was reached. 
The researchers uncovered that, when in a Mg depleted state; 80% max heart 
rate was reached at lower intensities, while, peak oxygen uptake, total cumulative 
net oxygen utilisation and heart rate were elevated for a given workload. The 
effects were directly correlated with the extent of Mg depletion while Mg repletion 
allowed a gradual return of the aforementioned variables to pre-depletion values. 
 
Brilla & Haley (1992) analysed whether supplementing additional Mg (261 
mg/day) (total of 8 mg/kg bodyweight/day) would warrant more strength 
improvement compared to individuals who were consuming around 246 mg/day 
(70% RDA) through diet and placebo. Both groups also conducted leg strength 
training exercise of 3 sets of 10 repetitions, 3 times per week. In this study, the 
participants who supplemented with Mg experienced significantly greater leg 
strength gains than those in the control group. The authors concluded that Mg 
coupled with strength exercise, may potentiate greater strength gains through an 
increase in protein synthesis which would in turn enable a faster increase in 
muscle protein density, in previously untrained individuals. The increase in 
protein density would subsequently enable higher numbers of actin-myosin 
bridges, resulting in greater force production and ultimately higher strength levels 
(Rude & Singer, 1981).  
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However, while the above studies support the claim that sub-RDA Mg intakes 
could negatively impact improvements in strength performance, evidence to 
support a benefit in adding supplemental Mg to a non-Mg deficient diet on 
strength is lacking. A study conducted by Brilla and Conte (2000) supplemented 
American football players (n=57) with either a daily dose of  Zinc Magnesium 
Aspartate (ZMA; 30 mg zinc, 450 mg Mg and 10.5 mg vitamin B6) or a placebo for 
8 weeks. There were no intra-group differences prior to the trial and mean group 
results (TMg) indicate adequate zinc and Mg status. Both groups increased in 
strength however, the ZMA group experienced higher strength increases 
measured by a dynamometer. Two other studies (Wilborn et al., 2004, and 
Moezzi, Peeri & Homaei, 2013) attempted to replicate these results in trained and 
untrained populations, with no significant effect for ZMA on strength levels, 
compared to placebo.  
 
Subsequently, following an analysis of the results in Deuster et al (1987) and 
other studies, Nielsen and Lukaski (2006) stated that the increased excretion of 
Mg in sweat and urine, justifies Mg requirements for exercising populations 
standing at 10-20% higher than those for statistically-matched sedentary 
individuals. Alternatively, these conclusions are directly in contrast with those of 
Newhouse and Finstad (2000), who; following a systematic review of the 
literature, observed that magnesium supplementation failed to augment exercise 
performance in trained populations. The authors suggested that Mg might work 
by addressing a weak link in the physiology of untrained subjects, while previous 
training would have already strengthened this weak link in trained athletes. 
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Following the theory of Brilla and Haley (1992) where Mg was theorised to play a 
role in protein synthesis; protein turnover was found to be lower in trained versus 
untrained (p < 0.01) individuals following resistance exercise (Phillips, Tipton, 
Ferrando & Wolfe, 1999). Subsequently, the observed reduced rate of protein 
breakdown following resistance exercise in trained subjects could indicate 
decreased Mg requirements in trained populations. Concomitantly, the transient 
increase in muscle Mg during exercise related with compartmental shifting could 
sufficiently act to negate the need for additional Mg in supporting exercise 
performance in trained populations (Newhouse & Finstad, 2000). 
 
Magnesium, anabolic hormones and antioxidant capacity 
Testosterone is an anabolic steroid hormone, and released by a cascade 
mechanism, following the pulsatile release of Leutinising Hormone (LH). 
Testosterone carriage within the blood generally consists of 53% free 
testosterone (95% of which is bound to albumin) and 47% bound to Sex-Hormone 
Binding Globulin (SHGB), which is considered biologically inert (Stanworth & 
Jones, 2008).  
 
Mg was suggested to potentiate strength augmentations through modulating 
anabolic hormones, specifically testosterone and insulin-like growth factor-1 
(IGF-1). Excoffon, Guillaume, Woronoff-Lemsi and Andre (2009), uncovered that 
Mg in biological concentrations, acts as an uncompetitive inhibitor to testosterone 
binding, increasing free testosterone within the body. This was supported by the 
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study of Brilla and Conte (2000) were the ZMA supplemented group exhibited 
increases in testosterone and also in IGF-1 which translated into strength 
augmentations. However, this increase in anabolic hormones was not replicable 
in 3 other studies supplementing with ZMA (Wilborn et al., 2004, Koehler et al., 
2009, and Moezzi, Peeri & Homaei, 2013). 
 
The American College of Sports Medicine (ACSM, 2006) states that; 
testosterone, whether endogenous or exogenous in origin, creates advantages 
in sport, implying an impact on strength levels. Similarly, chronically higher levels 
of endogenous testosterone in older men (70+ years) have been linked with lower 
BMI, lower fat mass index and higher strength and power levels but not increased 
lean body mass (Orwoll et. al., 2006). Natural variations in testosterone levels are 
believed to lead to an athletic advantage in the athletic world, as observed by the 
International Association of Athletics Federation banning women with 
testosterone levels > 10 nmol/L from competing (Karkazis, Jordan-Young, Davis 
& Camporesi, 2012).   
 
However, elevated resting testosterone for athletes, has been reported in some 
studies (Cinar, Polat, Baltaci, & Mogulkoc, 2011) but not in others (Kraemer & 
Ratamess, 2005). Following studies; Athiainen, Pakarinen, Alen, Kraemer, and 
Hakkinen (2003), and Kraemer et al (unpublished), observed an increase and a 
no change in free and total testosterone, following 7 and 2 weeks of high volume 
training, respectively, whereas testosterone levels decreased following a 
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decreased volume, high intensity training period (cited in Kraemer & Ratamess, 
2005). Similarly, a decrease in free testosterone (12%) was observed during 2 
weeks heavy training (Raastad, Glomsheller, Bjoro & Hallen, 2001), possibly due 
to a decrease in secretion of Leutinizing Hormone (LH) (Nindl et al., 2001). 
Subsequently, while increased Mg intake could be positively correlated with 
testosterone levels, exercise could also potentially modulate testosterone levels. 
 
Furthermore, Mg status has also been strongly and independently associated 
with serum IGF-1, and total testosterone levels in older (65+ years) men (Maggio 
et al., 2011). IGF-1 is considered another anabolic hormone of importance, given 
its role in the mediation of growth, cellular transformation and regeneration, as 
well as immune function, musculoskeletal development (Yakar, Wu, Setsen & 
Rosen, 2002). IGF-1, exerts an anabolic action similar to insulin by increasing 
amino acid uptake and stimulating protein synthesis, while suppressing protein 
degradation, directly contributing to skeletal muscle hypertrophy (Yarasheski, 
1994, cited in Ratzin-Jackson, 2000). Alternatively, rather than increased 
circulating IGF-1 contributing to increments in strength and muscle mass, 
hypertrophy itself is what leads to increased IGF-1 expression within skeletal 
muscle, via the mobilisation of satellite cells during the remodelling process 
(Ratzin-Jackson, 2000). Similarly, Stewart and Pell (2010) uncovered that IGFs 
contribute to myofibrillar protein accretion and satellite cell proliferation, 
differentiation, survival and recruitment, ultimately leading to fibre hypertrophy. 
Furthermore, IGF-1 within muscle has been shown to activate quiescent satellite 
cells and also act as an anabolic factor for differentiated muscle fibres 
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(Jacquemin, Furling, Bigot, Butler-Browne & Mouly, 2004). Subsequently, 
through increasing of IGF-1, increased Mg intakes could be positively correlated 
with an increase in lean body mass. 
 
Similarly, athletes performing resistance-training for >13 weeks were found to 
have 20% higher IGF-1 levels than their untrained counterparts (Borst et. al., 
2001). An acute rise in IGF-1 (13-26%) was also reported following 10 minutes 
after the initiation of high-intensity exercise however, IGF-1 levels were 
unchanged exactly after or in the 24 hours following exercise (Jenkins, 1999). 
Alternatively, a chronic decrease in IGF-1 (11%) was reported during a period of 
training intensity or volume overreaching (Raastad et al., 2001).  
 
Furthermore, Mg also plays an active role in decreasing oxidative stress within 
the human body (Dickens et al., 1992, cited in Maggio et al., 2011). Demirbag et 
al. (2005) uncovered that while total antioxidant capacity is positively correlated 
with endogenous testosterone and IGF-1 levels, the respective concentrations of 
anabolic hormones decrease after exposure to stress.  Consequently, Maggio et 
al. (2011) proposed that Mg, through its antioxidant capacity, aids in the 
downregulation of oxidative stress, attenuating stress related decreases in 
anabolic hormone levels. Both aerobic and nonaerobic exercise have been 
classified as contributors to oxidative stress (Alessio et al., 2000). Consequently, 
Mg, through its antioxidant capacity, could contribute to a decrease in exercise 
associated oxidative stress, attenuating the related downregulation of anabolic 
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hormones. This might be especially useful during periods of training intensity or 
volume overloading such as those reported in Raastad et al. (2001), which 
downregulated anabolic hormone production, specifically free testosterone (-
12%) and IGF-1 (11%) and consequently could potentially lead to decreased 
exercise performance. Therefore, higher Mg intakes for athletes, could serve as 
a warrant to enable athletes to tolerate higher exercise volumes and 
consequently, increase exercise performance.  
 
Conclusion 
Muscular strength has been independently correlated with longevity and 
increased quality of life. Similarly, adequate Mg status has been associated with 
muscular strength in some studies, but not in others. Population studies suggest 
that a considerable amount of the population exhibits marginal Mg deficiency as 
exhibited by suboptimal Mg intakes. Therefore, improving Mg status could directly 
imply decreasing the risk for the eventualities associated with decreased 
muscular strength and consequently, improving health and longevity. Several 
studies have concluded that Mg, through its roles in improving anabolic hormone 
profiles and increased antioxidant capacity, could augment strength performance 
while improving body composition and therefore, prove especially useful to 
exercising populations who require frequent high energy outputs and exhibit 
increased oxidative stress (Alves et al., 2012, Prasad et al., 1996, Maret & 
Sandstead, 2006, Lukaski & Nielsen, 2002). Furthermore, while increased food 
intake generally observed in athletes, could warrant increased Mg intakes, given 
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adequate food choices, studies analysing Mg intakes of athletes report that a 
considerable proportion demonstrate Mg intakes lower than RDA. Subsequently, 
athletes exhibiting increased physical activity and decreased food intake, might 
be at a higher risk of deficiencies of these minerals (Lukaski, 2000). 
 
Mg supplementation is an available option for those opting to increase intake of 
the respective mineral. Supplementation is available through various forms, 
ranging from oral supplements to soluble powders and topical solutions. 
Alternatively, while several supplemental options are available, their efficacy at 
raising Mg status, as assessed by common measurements of Mg status, varies 
for different forms and different compounds. Alternatively, given the fluctuating 
physiology of Mg amongst different body pools, the adequacy of the single use 
of any present method at determining Mg status has been questioned by several 
authors. Subsequently, numerous authors suggest the adoption of two or more 
measurements of Mg status to improve the reflection on whole body nutriture. 
  
In turn, based on present observations, some authors have reported that Mg 
physiology suggests increased requirements for populations undertaking regular 
bouts of physical activity at high intensities and training volumes, as justified by 
the increased utilisation and excretion of the mineral (Nielsen & Lukaski, 2006, 
McDonald & Keen, 1988). This is directly in contrast with suggestions made by 
other authors (Newhouse and Finstad, 2000); who argued that while increased 
22 
 
Mg intake may benefit untrained individuals, physiological remodelling in trained 
populations could negate the requirement for increased Mg intake.  
 
Subsequently, while supplementation has been provided as an option for 
populations not meeting adequate intakes of the mineral, given the positive link 
with Mg status, could potentially lead to strength increments. However, the 
evidence regarding the link is inconsistent. Consequently a systematic review; 
examining present literature could assist in analysing the possibility of a 
correlation between Mg supplementation and muscle strength, while underlining 
any existing confounding variables and gaps in the literature, and making 
suggestions for future research. 
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Abstract 
Background 
Magnesium physiology suggests a possible benefit for supplementation on 
strength and body composition, however evidence for a direct correlation is 
incoherent. 
Objectives 
To systematically analyse trials for evidence regarding the effects of magnesium 
supplementation on strength and body composition. 
Search methods 
Searches were conducted in Google Scholar, Sport Discus, Pubmed, WHO-
ICTRP, University of Chester Library, and databases of Italian journals. Authors 
were also contacted. There were no date restrictions. 
Selection criteria 
Trials supplementing with magnesium supplementation (any form) and 
measuring muscle strength or body composition, in comparison with a placebo 
or no treatment were included. 
Data collection and analysis 
Risk of bias was assessed using the PEDro scale. Data was collected from the 
retrieved version of the studies. 
Main results 
A total of 9 studies, encompassing 522 participants were included for muscle 
strength. 4 of these studies (298 participants) also analysed changes in body 
composition. There was a variety in dosing, form and duration of 
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supplementation. 3 studies were conducted on alcoholics, 3 on physically active 
individuals, 1 on elderly and 2 on untrained populations. Only 3 studies displayed 
a strength benefit for magnesium over placebo; 1 in alcoholics, untrained and 
physically active. Body composition changes were only significant in 1 study 
conducted on overweight, untrained middle-aged women. 
Conclusion 
The strength of the evidence points towards no benefit for magnesium 
supplementation on strength performance or body composition in 
normomagnesemic populations.  
 
Keywords: bioavailability, exercise, mineral status, muscle mass 
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Background 
Information regarding the trace element 
Magnesium (Mg) is an essential mineral and cofactor for over 300 enzymatic 
reactions involved in neuromuscular transmission, muscular contraction, oxygen 
uptake, energy production and electrolyte balance (Altura, 1991). Recommended 
Daily Allowances (RDAs) for Mg in adults stand at 400 and 310 mg/day, for males 
and females respectively (European Food Safety Authority, EFSA, 2015). 
Despite several dietary sources, subclinical or marginal Mg deficiency is 
prevalent worldwide (Nielsen, 2010). Supplemental Mg is available as capsules 
containing various salts of Mg such as; oxide, aspartate and citrate, with organic 
salts and chloride displaying higher bioavailabilities (Firoz & Graber, 2001). 
Soluble preparations, for intravenous (Garrison, Allan, Sekhon, Musini & Khan, 
2012), topical and transdermal supplemental methods are also available (Nica et 
al., 2015).   
 
Description of considered outcomes 
‘Muscle strength’ is defined in the medical subject heading (MeSH) PubMed 
database as; the amount of force generated by muscular contraction (Saey & 
Toosters, 2008). It is considered an indicator of nutritional status and predictor of 
decreased osteoporotic fracture, disability and mortality in both middle-aged and 
elderly (Rantanen et al., 2000, cited in Moslehi, Vafa, Sarrafzadeh and 
Foroushani, 2013). Also decreased muscle strength is directly correlated with an 
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independently increased risk for metabolic syndrome irrespective of age, body 
size, insulin resistance and central obesity (Jurca et al., 2005). Body composition 
is outlined as either; Fat Free Mass (FFM) and fat, or Lean Body Mass (LBM) and 
fat, with the difference between FFM and LBM being that, FFM includes essential 
fat around the organs, unlike LBM (Wang, Piersen & Heymsfield, 1992). 
 
Trace element physiology and the considered outcomes 
The positive association of Mg with energy production, protein synthesis (Brilla & 
Haley, 1992), anabolic hormone levels and antioxidant capacity (Maggio et al., 
2011), suggest that Mg supplementation may improve muscle strength and body 
composition. Consequently, while supplemented Mg can correct a deficiency it 
can also exhibit a pharmacological action if supplemented to non-deficient 
individuals (Lukaski, 2000). 
 
Rationale for review 
Supplementation with Mg has been suggested to be positively correlated with 
increases in strength performance in some studies but not in others (Newhouse 
& Finstad, 2000). Consequently a systematic review, assembling key articles, 
could assist towards outlining any related ergogenic benefits, while identifying 
gaps within the literature for future research.  
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Aims 
1. To investigate for any ergogenic effects of Mg supplementation on strength 
and body composition. 
 
Objectives 
1. To systematically analyse randomised controlled trials (RCTs) which utilise Mg 
supplementation and include strength performance or body composition as an 
outcome measure.  
 
Methods 
This section has been provided to clearly outline the search methods used to 
retrieve the relevant articles; including the relative search term/s, keywords, 
search engines and the associated inclusion/exclusion criteria.  
 
Formulating a focused research question 
Prior to conducting any literature search a research question should be 
formulated. The research question needs to be properly framed in order to enable 
the researcher to retrieve specific findings. Consequently, given a focused 
question, the results of the searches will be narrowed down to include as much 
relevant findings as possible (Aslam & Emmanuel, 2010). Given, the nature of 
the review question is similar to one conducted in clinical research, and some of 
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the best studies for such questions definitely include RCTs (Simon, 2001). PICO 
framework was adopted for the formulation of the research question. PICO stands 
for Population, Intervention, Comparison and Outcome and it was formulated for 
use in evidence-based medicine (Huang, Lin & Demner-Fushman, 2006). 
Furthermore, the PICO framework has shown to improve precision at retrieving 
high quality studies in widely utilised databases (Schardt, Adams, Owens, Keitz 
& Fontelo, 2007).  
 
Criteria for considering studies for this review 
Types of studies included 
RCTs comparing Mg supplementation with placebo or no supplementation were 
included. Other forms of trials, including RCTs with a cross-over design were also 
included. Retrieved studies had to be available in English or Italian language to 
be included. No date restrictions were applied. 
 
Types of participants 
The upcoming review included participants who were aged over 15 years of age. 
No restrictions of gender, ethnicity, health and physical activity status were 
applied. 
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Types of interventions 
Controlled trials utilising supplementation with Mg as an intervention were 
included. Control groups of studies could include supplementation with a 
matched-placebo or no supplementation.  
 
Interventions considered 
Magnesium supplementation: any form, duration and pattern of administration 
 
Comparators considered 
1. Adequate placebo 
 Not containing Mg or other minerals 
 
2. No supplementation 
 Control group not given a placebo 
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Outcome measures 
1. Strength 
The use of dynamometry and One-Repetition Maximum (1-RM) testing, being 
gold-standards for strength testing in-vivo (Verdijk, van Loon, Meijer & Savelberg, 
2009), and outside a lab (Levinger et al., 2009), respectively; were the preferred 
methods of measurement of strength performance. Grip strength though not 
being a gold-standard, was still considered an adequate measure of strength; as 
it can be particularly useful in measuring strength in older or hospitalised 
populations (Roberts et al., 2011). Maximal isometric contraction as a measure 
of strength testing has been validated for use in specialised populations (Visser 
et al., 2003 & Zimmer et al., 2013) and consequently, was also included. 
Subsequently, the strength measures considered, included:  
 Handgrip strength 
 5-second isometric bench press contractions 
 Isometric strength 
 Isokinetic torque 
 1-RM Bench press 
 
2. Body Composition 
The validity of any given body composition test varies for different populations, 
(Heymsfield, Lohman & Wang, 2005, cited in Duren et al., 2008) as those 
considered in this review. Consequently a variety of body composition tests were 
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included ranging from Dual X-Ray Absorptiometry (DXA) to Bioelectrical 
Impedance Analysis (BIA). One study also included measurement of muscle 
mass through 24-hour creatinine excretion. Subsequently, outcomes included 
consisted of the measurement of; 
 LBM 
 FFM 
 Fat mass 
 Muscle mass (through biochemical analysis) 
 
The Search strategy  
Identification of keywords 
Following the formulation of the question, keywords were generated and placed 
within the different sections of the PICO paradigm (Table 1). The words within the 
table represent the study characteristics considered, their respective synonyms 
and truncations, as well as their placement within the PICO paradigm. 
Subsequently, studies considered were to fit a minimum of 1 characteristic under 
every column in order to be included. 
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Table 1: Keywords utilised during the search for articles, within the PICO paradigm 
Population Intervention Comparison Outcome 
‘adult’ ‘magnesium 
supplementation’ 
‘placebo’ ‘strength’ 
‘adults’ ‘Mg’ ‘no 
supplementation’ 
‘body composition’ 
‘athlete’  ‘control group’ ‘resistance training’ 
‘athlete’   ‘body fat’ 
 
The search strategy was developed utilising guidelines from Cochrane (2007). 
PubMed’s Medical Subject Headings (MeSH) database was used to uncover any 
further relevant synonyms in the process. The MeSH database is the U.S. 
National Library of Medicine controlled thesaurus (U.S. National Library of 
Medicine, 2015). 
 
From the Intervention section, the term ‘Magnesium’ is considered a wide term 
due to the wide variety of salts available, however, all synonyms uncovered 
through Pubmed’s MeSH database contained the aforementioned word. The 
term ‘Mg’ was also utilised as it sometimes is used as an acronym for the element. 
From the ‘Population’ section; the term ‘adults’, was inserted in PubMed’s MeSH 
database, however no other relevant synonyms that did not contain the word 
‘adult’ were uncovered. Finally given inclusion criteria included some form of 
‘strength’ measurement the term was entered in the MeSH database. This term 
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uncovered several terms including: ‘muscle strength’, ‘resistance training’, 
‘athletes’, ‘strength training’, ‘grip strength’ and ‘hand strength’. The term strength 
was kept when retrieved keywords contained the word. Alternatively, synonyms 
devoid of the respective word were also utilised. The term ‘athletes’ was then 
controlled for truncations to uncover the term ‘athlete’. These 2 terms were then 
placed under their respective subheading: ‘Population’. 
 
A preliminary search was then conducted in Google Scholar. Following this, 
subsequent searches were conducted utilising online databases; Medline, Wiley 
Online Library, SPORTDiscus, University of Chester Library, Research Gate, 
World Health Organisation-International Controlled Trials Registry Platform 
(WHO-ICTRP), Medicina dello Sport and Sport & Medicina. Boolean search 
phrases, filters and wildcard searches were utilised when possible to enable the 
search to be more refined. No restrictions regarding publication date and 
publication status were applied. Articles available in English and Italian 
languages were considered 
 
Electronic searches 
Google Scholar 
The database was searched utilising a total of 3 keywords from the ‘Intervention’ 
and ‘Outcome’ sections. In order to allow a focused search, settings were applied 
so that keywords entered had to be present in the title. 
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SPORTDiscus (January 1975 to August 2015) 
SPORTDiscus was searched using a combination of the one of the keywords 
under the ‘Intervention’ heading in Table 1 combined with those under the 
‘Outcome’ heading.  
Free text = ‘magnesium supplementation’ or ‘Mg’ AND ‘strength*’ or ‘body 
composition’ or ‘body fat’ or ‘resistance training’. 
 
Keyword = ‘Mg’ AND Free text = ‘strength*’ or ‘body composition’ or ‘body fat’ or 
‘resistance training’. 
 
Medline through Pubmed (January 1966 to August 2015) 
Keywords from the ‘Intervention’ and ‘Outcome’ section were utilised. Some 
searches are very wide when applied to Medline. However, the Dietary 
Supplements filter was applied and ‘Title/Abstract’ was selected in the search 
builder. The Boolean search phrase AND was also used. Searches were 
conducted as follows: 
Title/abstract = ‘magnesium supplementation’ or ‘Mg’ AND  
Title/Abstract = ‘strength*’ or ‘body composition’ or ‘body fat’ or ‘resistance 
training’. 
The publication type: ‘Randomized Controlled Trial’ could have been utilised in 
Medline to exclude only such types of studies. However, it was not used as, 
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according to Glanville, Lefebvre, Miles and Camosso-Stefinovic (2006) this could 
discriminate against potential such studies, if they are not classified under the 
respective section. 
 
University of Chester Library 
The University of Chester has a unique feature ‘Library Search’, enabling the user 
to search the entire library including books, journals and dissertations. The 
aforementioned search feature was used and filters for; ‘Electronic resources’, 
‘Dissertation’, ‘Journal/eJournal’ and ‘Journal Articles’ were selected. Also, the 
‘diet and clinical nutrition’ discipline was selected. Consequently, searches were 
conducted utilising keywords from the ‘Intervention’ (present in the Title) in 
combination with keywords from the ‘Outcome’ section, (present in the abstract) 
as follows: 
Title = ‘magnesium supplementation’ OR ‘Mg’ AND 
Abstract = ‘strength*’ or ‘body composition’ or ‘resistance training’ or ‘body 
composition’ or ‘body fat’. 
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WHO-ICTRP  
The database WHO-ICTRP was searched utilising combinations of keywords 
from ‘Intervention’ and ‘Outcome’ sections, in an attempt to uncover any further 
published, unpublished or ongoing trials. 
 
Other electronic searches 
Research Gate and Wiley Online Library were also searched for any published 
or unpublished studies meeting the inclusion criteria, utilising a combination of 
keywords from the Intervention and Outcome sections. 
 
Italian journal databases 
The database of the Italian journals ‘Medicina dello sport’ and ‘Sport & Medicina’ 
were also searched. Searches uncovering any articles containing any 
combination of a keyword from the ‘Intervention’ column and a keyword from the 
‘Outcome’ column were conducted. 
 
Personal Communication 
Researchers in the field were contacted through ‘Research Gate’ for additional 
information regarding the respective inclusion criteria. Authors of articles in other 
languages, apart from the ones included, were also contacted and asked 
regarding any available versions in one of the included languages. 
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Handsearching 
Retrieved studies, conferences proceedings, major textbooks and previous 
systematic reviews available in included languages were checked for further 
published or unpublished research. 
 
Data collection and analysis 
Selection of studies 
Any studies which met the inclusion criteria were considered and their respective 
full texts were retrieved. Inclusion criteria consisted of: 
 RCTs or cross-over trials 
 Considered an intervention group supplemented solely with Mg 
 Utilised one or more strength performance measures as an outcome 
 Participants aged over 15 years of age 
The studies generated by the search methods were reviewed primarily based on 
title and abstract. Subsequently, retrieved articles were re-assessed based on 
respective inclusion criteria. When duplicate publications were present only one 
was included.  
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Data extraction 
Data regarding study variables was extracted from selected studies, including: 
 study design 
 participant characteristics (age, sex, physical activity status, comorbidities) 
 any assessment for dietary Mg 
 any measurements of Mg status 
 intervention details (dose and duration of supplementation) 
 any exercise regimen performed in conjunction with supplementation 
 outcome measures of interest (strength and body composition) 
 comparator details 
 
Methodological quality assessment 
The Physiotherapy Evidence Database, PEDro scale (1999) was utilised as a tool 
to assess methodological quality of included studies. The PEDro scale rates 
quality of trials on 11 criteria and a ‘yes’ answer for any of criteria 2-11 involves 
adding 1 to the score. It was developed using the Delphi tool, which in turn was 
rated as the highest of 7 most commonly utilised trial assessment tools in 
systematic reviews (Berger & Alperson, 2009). The tool enables the user to 
account for: selection, performance, attrition, detection, and reporting biases 
within each study. 
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Cross-over trials 
A concern with cross-over trials might be the carry-over effect. This due to the 
fact that physiological differences related to any treatment in the first phase, might 
increase the risk of bias during the second phase. A washout period to ensure 
homogeneity of subjects prior to the initiation of the second-phase, was 
considered adequate. 
 
Results 
Description of studies 
Results of the search 
Through an analysis of the title, electronic searches retrieved 36 studies: 6, 7, 12, 
5, 1, and 5 in Google Scholar, SportDiscus, MEDLINE, University of Chester 
Library, WHO-ICTRP and Research Gate, respectively. Handsearching of 
retrieved articles uncovered 2 more potential studies. Following the reading of 
abstracts 27 studies were excluded. Authors were contacted when full-text was 
not retrieved, or retrieved versions were not in English or Italian language version. 
11 studies available in full-text were retrieved. Of these; the author of 1 study 
confirmed it was not available in English language and another did not include a 
supplementation protocol. The remaining 9 studies were further evaluated, met 
the inclusion criteria and were considered for this review. (Figure 1) 
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Figure 1: Flow diagram 
36 articles retrieved through 
electronic searches
38 articles
2 articles retrieved through 
handsearching
3 articles did not measure 
strength performance
24 studies not relevant for 
review
1 study not available in 
English or Italian language
11 articles retrieved in full 
text
10 articles considered for 
the review
1 study did not include 
supplementation
 
Included studies 
A summary of the characteristics for each of the included studies can be found in 
Appendix 1 (Characteristics and risk of bias of included studies). Below is the 
summation of all the global characteristics for all studies included in this review, 
by study variable. 
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Study designs 
Included studies consisted of randomised controlled trials (RCTs), one of which 
had a cross-over design. The control group was either supplemented with a 
placebo or not supplemented, and in the cross-over design a 1 week washout 
period was allowed in between.  
 
Sample sizes 
A total of 522 participants were included. Sample size in studies varied from 139 
(Veronese et al., 2014) to 13 (Kass & Poeira, 2015). 
 
Participant characteristics 
Age of participants between 15-20 years of age in Setaro et al. (2014) to mean 
age in Veronese et al. (2014) being 71.5 years. Certain studies included solely 
female subjects (Moslehi, Vafa, Sarrafzadeh & Rahimi-Foroushani, 2013 and 
Veronese et al., 2014), others included exclusively male participants (Kass, 
Skinner & Poeira, 2013 and Setaro et al., 2014) while others included participants 
of both sexes. One study did not mention gender of participants (Brilla and Haley, 
1992). Physical activity status of participants also varied from professional 
athletes in Setaro et al. (2014), to untrained populations in Brilla and Haley 
(1992). Also, participants were of varying health status from with some studies 
including exclusively: alcoholics (Gullestad et al., 1992 and Poikolanen & Alho, 
2008) and patients with alcoholic liver disease (Aagaard et al., 2005). Other 
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studies included solely overweight participants (Body Mass Index (BMI): 25-30 
kg/m2).  
 
Dietary assessments 
Dietary magnesium could act as a confounding variable which could buffer or 
augment the ergogenic effect of supplementation. The majority of studies (5 
studies) included some form of dietary assessment to analyse dietary magnesium 
intake. Others (3 studies) did not. For one study (Gullestad et al., 1992) the 
authors reported that all participants were told to minimise alcohol and 
magnesium-rich food consumption. 
 
Magnesium status 
Mg status would be considered as another confounding variable. Consequently, 
measuring such could ensure homogeneity between groups. Serum magnesium 
was taken in 4 studies to ensure homogeneity among groups. Other studies 
utilised different measures including muscle magnesium (Aagaard et al., 2005) 
and plasma magnesium (Setaro et al., 2014). 3 studies did not measure 
magnesium levels. 
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Intervention and comparators 
Dosing of oral magnesium varied from 250 mg/day (Moslehi, Vafa, Sarrafzadeh 
& Rahimi-Foroushani, 2013) to 500 mg/day (Poikolanen & Alho, 2008). One study 
reported total dietary and supplemented magnesium as being 8 mg/kg 
bodyweight/day in intervention group (Brilla & Haley, 1992). Another study 
utilised exclusively 728mg of intravenous Mg sulfate on the first 2 days, followed 
by solely oral supplementation (Aagaard et al., 2005). Different magnesium salts 
were supplemented, the most common being oxide, citrate and sulfate. 
 
Training regimens conducted 
The majority of studies did not alter physical activity, for the duration of the study. 
One study included a strength training program consisting of 3 sets of 10 
repetitions leg press and leg extension 3 times per week. For the remaining 8 
studies participants either were advised to keep a constant level of physical 
activity or physical activity was not measured. 
 
Excluded studies 
Excluded studies were either; not available in English or Italian languages, did 
not include a magnesium treatment arm, or did not consider strength or body 
composition as an outcome measure. 
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Risks of bias in included studies 
The judgement for the risk of bias for separate studies can be found in Appendix 
1 (Characteristics and Risks of bias in included studies). Below is a summative 
report of the measures, taken by the authors of the included studies, which could 
affect the risks of bias. 
 
Randomisation 
Randomisation in most studies (8 studies) was done utilising participants as the 
unit of randomisation. One study (Setaro et al., 2014) utilised urinary magnesium 
as the unit of randomisation. 
 
Allocation (selection bias) 
Only 2 studies (Aagaard et al., 2005 and Veronese et al., 2014) mentioned some 
form of allocation concealment, stating that allocation sequence was kept 
confidential.  
 
Blinding (performance and detection bias) 
Participants in studies which did not include a placebo-controlled group, were not 
considered as being blinded, as subjects would have been able to distinguish 
whether they were supplementing or not (Veronese et al., 2014 and Kass & 
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Poeira, 2013). Furthermore, in some of the studies it was unclear whether 
assessors were blinded or not. 
 
Attrition bias 
Some studies had high rates of dropouts: 28% (Aagard et al., 2005) and 50.8% 
(Poikolainen & Alho, 2008). The latter study conducted an intention-to-treat 
analysis. 
 
Other potential sources of bias 
One study (Gullestad et al., 1992) advised all participants to minimise alcohol and 
magnesium-rich food consumption. No dietary assessment was conducted 
before or after the trial. 
 
Effects of treatment 
A summary of the effects of treatment for the separate considered outcomes can 
be found in Appendix 2 
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Strength 
Strength increase was found to be significantly higher in 3 studies (Gullestad et 
al., 1992, Brilla & Haley, 1992, and Kass & Poeira, 2015), when compared to 
respective control groups. 
 
Body composition 
Only 1 study uncovered significantly different body composition between 
intervention and control groups at the end of the trial (Moslehi, Vafa, Sarrafzadeh 
& Foroushani, 2013).   
 
Discussion 
Magnesium supplementation and strength 
Gullestad et al. (1992), after conducting a study on alcoholics, uncovered a 
significantly higher increase in strength for the Mg supplemented (375 mg/day) 
group, however, no dietary assessment was conducted, and prior to the study, 
all participants were advised to reduce alcohol and intake of Mg-rich foods. Mean 
serum Mg levels decreased (0.84 to 0.79 mmol/L), in the control group and 
increased (0.86 to 0.88 mmol/L) in the treated group. Subsequently, the positive 
effect for Mg supplementation on strength could be explained, at least in part, by 
the uncompensated decreased dietary Mg, which reflected through a reduction 
in Mg status in the control group, while Mg supplementation addressed the 
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deficiency in the intervention group and therefore, indicating a disruption in 
synergy between groups.  
 
Some studies did not account for dietary Mg and Mg status which could act as 
confounding variables. The study conducted by Brilla and Haley (1992) suggests 
that; Mg supplementation could exhibit an ergogenic effect and potentiate further 
augmentations in strength performance, when combined with a resistance 
training program, in untrained subjects. However, the control group of this study 
was only having 246mg (70% RDA, as stated by authors), while the intervention 
group was having 504mg (144% RDA). Kass and Poeira (2015) also uncovered 
significantly higher (17.7%) increases in strength (1-RM bench press) for 1 week 
(300mg/day or 300mg prior to exercise on exercise days) Mg supplementation 
when compared to placebo. The results of this study could be explained by the 
use of Mg citrate which is known to have improved absorption (50%) when 
compared to 4% for Mg oxide (Firoz & Graber, 2001). Measures of Mg status 
were not included, however, both acute intervention and acute placebo groups 
had dietary Mg intakes positive of 350 mg/day at baseline. Alternatively, another 
arm of the latter study included participants (mean dietary Mg; 361mg/day) 
supplementing with Mg (300mg/day) for 4 weeks and did not find a difference in 
strength (1-RM bench press) when compared with a control group (mean dietary 
Mg; 551 mg/day). Subsequently, the effects of Mg supplementation in the chronic 
(4 week) arm of the study could have been buffered by the higher dietary Mg in 
the control group. Another study, (Moslehi, Vafa, Sarrafzadeh & Foroushani, 
2013) considering participants (150 < mean Mg dietary intake (mg/day) < 200), 
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but were considered of normal Mg status (according to serum Mg), found no 
significant difference in strength between treated and control groups, following 8 
weeks of Mg supplementation (250 mg/day).  
  
Alternatively, Mg’s role in protein synthesis would suggest that optimal intakes of 
Mg may assist strength augmentations, stimulated through physical activity (Brilla 
& Haley, 1992). However, training-associated compartmental shifting of Mg, 
could increase Mg muscle content, negating the requirement for additional Mg, 
especially in trained athletes (Newhouse & Finstad, 2000). This is directly in line 
with the observations of Setaro et al. (2014), the only included study, on 
professional athletes. 
 
Magnesium supplementation and body composition 
Only one of the included studies uncovered a significant increase and decrease 
in mean lean body mass (0.7 kg, p = 0.05) and fat mass (1 kg, p = 0.02), 
respectively, following Mg supplementation (250 mg/day for 8 weeks) when 
compared to baseline. Alternatively, body composition changes in the control 
group of the respective study were not significant. Mean physical activity 
decreased in both intervention (438 to 363 Met-min/week) and placebo (420 to 
383 Met-min/week) groups, however this change was not-significant. 
Alternatively, all other studies following supplementation with higher doses of 
supplemental Mg (271<Mg mg/day<300), some of which for longer periods of 
time (12 weeks in Veronese et al., 2014), and combined with an increase in 
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physical activity (Brilla & Haley, 1992), uncovered no significant differences in 
body composition. However, while mean BMI of participants in Moslehi, Vafa, 
Sarrafzadeh and Foroushani (2013) and Veronese et al. (2014) were similar (28 
and 27.4 (kg/m2), respectively), Moslehi, Vafa, Sarrafzadeh and Foroushani 
(2013) was the only study which included solely overweight women.  
 
Suggestions for future research 
The lack of significant results for strength outcomes could be attributable to 
numerous factors. Oral supplementation with Mg oxide, as utilised in the majority 
of studies, is poorly absorbed (4%) when compared to other Mg salts, such as 
Mg citrate (50%) (Firoz & Graber, 2001). Alternatively, Mg supplementation 
through transdermal application of 31% Mg chloride formulation was found to be 
more effective at raising serum Mg than oral supplementation. Furthermore, as 
also argued in Newhouse, Johnson, Montelpare, and McAuliffe (2002), serum 
and plasma TMg are not necessarily reflective of whole Mg status. Subsequently, 
multiple tests of higher reliability such as ionic Mg (iMg) validated against Mg 
loading with 24 hour urinalysis, could prove more useful for the determination of 
Mg status (Newhouse & Finstad, 2000).  
 
Conclusion 
The conclusions are in line with those of other authors, where majority of the 
evidence indicates no strength performance benefit related with supplementing 
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normomagnesemic populations with oral Mg. Some salts of Mg, including Mg 
citrate, could possibly be correlated with some degree of ergogenesis on strength 
performance, following acute supplementation. Body composition in overweight 
populations might be positively affected following Mg supplementation. However, 
further research; with more participants, of different athletic levels, controlling for 
confounding variables such as dietary Mg and Mg status through more than one 
method, and utilising more bioavailable sources of Mg, would be suggested to 
aid ascertain any possible correlations between ergogenic strength benefits and 
all forms of supplementation. 
 
 
 
 
 
 
 
 
 
 
 29 
  
References 
Aagard, N.K., Andersen, H., Vilstrup, H., Clausen, T., Jakobsen, J., & Dorup, I. 
(2005). Magnesium supplementation and muscle function in patients with 
alcoholic liver disease: A randomised placebo-controlled trial. Scandinavian 
Journal of Gastroeneterology, 40, 972-979. 
Aslam, S., & Emmanuel, P. (2010). Formulating a researchable question: A 
critical step for facilitating good clinical research. Indian Journal of Sexually 
Transmitted Diseases, Jan-Jun 31(1), 47-50. doi: 10.4103/0253-7184.69003 
Berger, V.W., & Alperson, F.Y., (2009). A general framework for the evaluation 
of clinical trial quality. Reviews on Recent Clinical Trials, May 4(2), 79-88. 
Brilla, L., & Haley, T.F. (1992). Effect of magnesium supplementation on 
strength training in humans. Journal of the American College of Nutrition, 11(3), 
326-329. Doi: 10.1080/07315724.1992.10718233. 
Cochrane (2007). How to develop a search strategy for a cochrane review. 
Cochrane Haematological Malignancies Group, Naumann, 1-10. Retrieved 
from: http://chmg.cochrane.org 
Duren, D.L., Sherwood, R.J., Czerwinski, S.A., Lee, M., Choh, A.C., … 
Chumlea, W.C. (2006). Body composition methods: comparisons and 
interpretation. Journal of Diabetes Science and Techonology, 2(6), 1139-1146. 
Firoz, M., & Graber, M. (2001). Bioavailability of US commercial magnesium 
preparations. Magnesium Research, 14, 257-262. 
 30 
  
Garrison, S.R., Allan, G.M., Sekhon, R.K., Musini, V.M., & Khan, K.M. (2012). 
Magnesium for skeletal muscle cramps.  Cochrane Database of Systematic 
Reviews (Online). Doi: 10.1002/14651858.CD009402.pub2 
Glanville, J.M., Lefebvre, C., Miles, J.N., & Camosso-Stefinovic, J. (2006). How 
to identify randomized controlled trials in MEDLINE: ten years on. Journal of the 
Medical Library Association, 94(2), 130-136. 
Gullestad, L., Dolva, O.L., Soyland, E., Manger, A.T., Falch, D., & Kjekshus, J. 
(1992). Oral magnesium supplementation improves metabolic variables and 
muscle strength in alcoholics. Alcoholism: Clinical and Experimental Research 
16(5), 986-990. Doi: 0145-6008/92/1065-098653.00/0 
Huang, X., Lin, J., & Demner-Fushman, D. (2006). Evaluation of PICO as a 
knowledge representation for clinical questions. AMIA Annual Symposium 
Proceedings, 359-363. PMCID: PMC1839740. 
Jurca, R., Lamonte, M.J., Barlow, C.E., Kampert, J.B., Church, T.S., & Blair, 
S.N. (2005). Association of muscular strength with incidence of metabolic 
syndrome in men. Medicine and Science in Sports and Exercise, 37, 1849–
1855. 
Kass, L., & Poeira, F. (2015). The effect of acute vs chronic magnesium 
supplementation on exercise and recovery on resistance exercise, blood 
pressure and total peripheral resistance on normotensive adults. Jopurnal of the 
Internation Society of Sports Nutrition 12(19). Doi: 10.1186/s12970-015-0081-z 
 31 
  
Kass, L., Skinner, P., & Poeira, F. (2013). A pilot study on the effects of 
magnesium supplementation with high and low habitual dietary magnesium 
intake on resting and recovery from aerobic and resistance exercise and 
systolic blood pressure. Journal of Sports Science and Medicine, 12, 144-150 
Levinger, I., Goodman, C., Hare, D.L., Jerums, G., Toia, D. and Selig, S. 
(2009). The reliability of the 1RM strength test for untrained middle-aged 
individuals. Journal of Science and Medicine in Sport 12 (3), 310-316. 
Lukaski, H.C. (2000). Magnesium, zinc and chromium nutriture and physical 
activity. American Journal of Clinical Nutrition, 72(suppl), 585s-593s. 
Maggio, M., Ceda, G.P., Lauretani, F., Cattabiani, C., Avantaggiato, E., … 
Ferrucci, L., (2011). Magnesium and anabolic hormones in older men. 
International Journal of Andrology, 34, e594-e600. doi:10.1111/j.1365-
2605.2011.01193.x 
Moslehi, N., Vafa, M., Sarrafzadeh, J., & Foroushani, A. (2013). Does 
magnesium supplementation improve body composition and muscle strength in 
middle-aged overweight women? A double-blind, placebo-controlled, 
randomised clinical trial. Biological Trace Element Research, 153, 111-118. Doi: 
10.1007/s12011-013-9672-1. 
Newhouse, I.J., & Finstad, E.W. (2000). The effects of magnesium 
supplementation on exercise performance. Clinical Journal of Sport Medicine, 
10, 195-200. 
 32 
  
Newhouse, I.J., Johnson, K.P., Montelpare, W.J., & McAuliffe, J.E. (2002). 
Variability within individuals of plasma ionic magnesium concentrations. BMC 
Physiology, 2(6). PMCID: 113254. 
Nica, A.S., Caramoci, A., Vasilescu, M., Ionescu, A.M., Paduraru, D., & Mazilu, 
V. (2015). Magnesium supplementation in top athletes – effects and 
recommendations. Journal of the Romanian Sports Medicine Society, Medicina 
Sportiva, vol. XI(1), 2482-2494 
Nielsen, F.H. (2010). Magnesium, inflammation and obesity in chronic disease. 
Nutrition Reviews, 68, 333-340. 
Physiotherapy Evidence Database (1990). PEDro Scale. Retrieved from 
Physiotherapy Evidence Database website: http://www.pedro.org.au/ 
Poikolainen, K., & Alho, H. (2008). Magnesium treatment in alcoholics: A 
randomised clinical trial. Substance Abuse Treatment, Prevention and Policy, 
3(1). Retrieved from: http://www.substanceabusepolicy.com/content/3/1/1 
Roberts, H.C., Denison, H.J., Martin, H.J., Patel, H.P., Syddall, H., … Sayer, 
A.A., (2011). A review of the measurement of grip strength in clinical and 
epidemiological studies: towards a standardised approach. Age Ageing, 40(4), 
423-429. doi: 10.1093/ageing/afr051 
Saey, D., & Troosters, T. (2008). Measuring skeletal muscle strength and 
endurance: from bench to bedside. Clinical and Investigative Medicine 31(5), 
E307-E311. 
 33 
  
Schardt, C., Adams, M.B., Owens, T., Keitz, S., & Fontelo, P. (2007). Utilization 
of the PICO framework to improve searching PubMed for clinical questions. 
BMC Medical Informatics and Decision Making 7(16). doi: 10.1186/1472-6947-
7-16 
Setaro, L., Santos-Silva, P.R., Nakano, E.Y., Sales, C.H., Nunes, N., … Colli, C. 
(2014). Magnesium status and the physical performance of volleyball players: 
effects of magnesium supplementation. Journal of Sport Sciences 32(5), 438-
445. Doi: 10.1080/0264014.2013.828847 
Simon, S.D. (2001). Is the randomised clinical trial the gold standard of 
research? Journal of Andrology, Nov-Dec 22(6), 938-943. PMID: 11700857. 
U.S. National Library of Medicine. (2015). Introduction: What is MeSH? 
Retrieved from: http://www.nlm.nih.gov/ 
Verdijk, L.B., van Loon, L., Meijer, K., & Savelberg, H.H. (2009). One-repetition 
maximum strength test represents a valid means to assess leg strength in vivo 
in humans. Journal of Sports Science, Jan 1; 27(1), 59-68. 
doi:10.1080/02640410802428089. 
Veronese, N., Berton, L., Carraro, S., Bolzetta, F., De Rui, M., ... Sergi, G. 
(2014). Effect of oral magnesium supplementation on physical performance in 
healthy elderly women involved in a weekly exercise program: a randomised 
controlled trial1-3. The American Journal of Clinical Nutrition, 100, 974-981. 
 
 34 
  
Visser, J., Mans, E., de Visser, M., van den-Berg-Vos, R.M., Franssen, H., … 
de Haan, R.J. (2003). Comparison of maximal voluntary isometric contraction 
and hand-held dynamometry in measuring muscle strength of patients with 
progressive lower motor neuron syndrome. Neuromuscular Disorders, Nov 
13(9), 744-750. 
Wang, Z.M., Piersen, R.M., & Heymsfield, S.B. (1992). The five-level model: a 
new approach to organising body composition research. American Journal of 
Clinical Nutrition, 56, 19-28. 
Wilson, J. W., Enns, C. W., Goldman, J. D., Tippett, K. S., Mickle, S. J., 
Cleveland, L. E. & Chahil, P. S. (1997). Data tables: combined results from 
USDA’s 1994 and 1995 Continuing Survey of Food Intakes by Individuals and 
1994 and 1995 Health Knowledge Survey. United States Department of 
Agriculture, Agricultural Research Service, Food Surveys Research Group, 
Beltsville, MD. Retrieved from: http://www.ars.usda.gov 
Zimmer, P., Baumann, F.T., Ebel, J., Zopf, E.M., Bloch, W., & Elter, T. (2013). 
Feasibility of an isometric maximal voluntary contraction test in haematological 
cancer patients during thrombocytopenia. Journal of Sports Medicine, 2013, 1-
6. Article ID: 470489.
Appendix 1: Characteristics and Risks of bias of Included studies 
35 
  
Study 1: Characteristics of study 
Author/s: Moslehi, Vafa, Sarrafzadeh & Foroushani, 2013 
Design Randomised, double-blind, placebo-controlled trial 
Participants 
74 females, aged 40-55 years (mean ± SD age: 46.3 ± 4.2 years), overweight 
(25≤BMI≤30 kg/m²), healthy and not suffering from any chronic diseases, non-
smokers and not taking magnesium-containing medications. 
Dietary assessment 
(magnesium mg/day) 
24-hour food recalls for 2 days (1 weekday and 1 weekend day); mean ± SD: 
158.1 ± 61.9 in intervention and 154 ± 58.4 in control, at baseline. After 8 weeks: 
157.2 ± 55.6 in intervention and 150.6 ± 49.8 in control 
Magnesium status 
Serum magnesium (mmol/L); mean ± SD: 0.9 ± 0.1 in intervention and 0.9 ± 0.1 in 
control. No changes reported after 8 weeks. 
Intervention 250 mg/day magnesium oxide for 8 weeks 
Comparator placebo containing cornstarch, lactose and stearic acid 
Training regimen 
No specific training regimen but a physical activity questionnaire was used to 
report physical activity (Met-Min/Weeks), and subjects were advised to maintain 
same level of physical activity. (Activity levels decreased) 
Outcomes of interest 
Handgrip strength test in dominant hand using a calibrated (DIGI-II, Korea) digital 
hand-held dynamometer, highest of 3 measurements. Isometric knee extension 
strength (kg) in dominant leg using a Nicholas Manual Muscle Tester; Lafayette 
Inc, highest of 3 measurements. Body Composition measured using a Quad Scan 
4000; Bodystat, Bioelectrical Impedance Analyser  
Study 1: Risk of bias assessment 
Item Answer 
Were eligibility criteria specified? 
Yes 
Were subjects randomly allocated to groups? 
Yes 
Was allocation concealed? 
Don't 
know 
Were groups similar at baseline for the most prognostic indicators? 
Yes 
Was there blinding of all subjects? 
Yes 
Was there blinding of all therapists? 
Yes 
Was there blinding of all assessors? 
Yes 
Were measures of at least one key outcome available for over 85% of initial 
subjects? 
Yes 
Was there an intention-to-treat analysis? 
No 
Was there a between-group statistical comparison? 
Yes 
Does the study provide point measures and measures of variability for at least one 
key outcome? 
Yes 
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Study 2: Characteristics of study 
Author/s: Brilla and Haley, 1992 
Design Randomised, double-blind, placebo-controlled trial 
Participants 26 untrained subjects, aged 18-30 years old 
Dietary assessment 
(magnesium mg/day) 
3-day measured diet record (246 mg/day; 70% of RDA as stated by authors) 
Magnesium status Not measured 
Intervention 
Participants in the intervention group were supplemented accordingly with 
magnesium oxide to reach total oral magnesium intake of 8 mg/kg 
bodyweight/day for 7 weeks (approx. 261 mg/day) 
Comparator sugar caplet as placebo 
Training regimen 
3 sets of 10 reps leg press and leg extension at 70% maximum voluntary 
contraction, 3 times per week 
Outcomes of interest 
Isokinetic quadriceps torque (Nm) measured with Orthotron dynamometer. Body 
composition measured with Bodycomp Light unit, Biolelectrical Impedance 
Analyser 
 
Study 2: Risk of bias assessment 
Item Answer 
Were eligibility criteria specified? 
Yes 
Were subjects randomly allocated to groups? 
Yes 
Was allocation concealed? 
Don't 
know 
Were groups similar at baseline for the most prognostic indicators? 
Yes 
Was there blinding of all subjects? 
Yes 
Was there blinding of all therapists? 
Yes 
Was there blinding of all assessors? 
Yes 
Were measures of at least one key outcome available for over 85% of initial 
subjects? 
Yes 
Was there an intention-to-treat analysis? 
Don't 
know 
Was there a between-group statistical comparison? 
Yes 
Does the study provide point measures and measures of variability for at least one 
key outcome? 
Yes 
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Study 3: Characteristics of study 
Author/s: Setaro et al., 2010 
Design Randomised, double-blind, placebo-controlled trial 
Participants 25 professional male, (15-20 years of age) volleyball players 
Dietary assessment 
(magnesium mg/day) 
None 
Magnesium status 
Plasma magnesium (mmol/L); mean ± SD: 0.9 ± 0.17 in intervention and 0.99 ± 
0.2 in control, at baseline. After 4 weeks; 0.82 ± 0.7 in treated and 0.85 ± 0.07 in 
control. 
Intervention 175 mg twice daily (350 mg/day) of magnesium oxide for 4 weeks 
Comparator 250 mg twice daily (500 mg/day) of maltodextrin 
Training regimen no change (6 hours per day of volleyball training) 
Outcomes of interest 
Isokinetic torque (Nm) in knee flexors and extensors measured with Biodex 
Medical Systems Pro® dynamometer 
 
Study 3: Risk of bias assessment 
Item Answer 
Were eligibility criteria specified? 
Yes 
Were subjects randomly allocated to groups? 
Yes 
Was allocation concealed? 
Don't 
know 
Were groups similar at baseline for the most prognostic indicators? 
Yes 
Was there blinding of all subjects? 
Yes 
Was there blinding of all therapists? 
Yes 
Was there blinding of all assessors? 
Yes 
Were measures of at least one key outcome available for over 85% of initial 
subjects? 
Yes 
Was there an intention-to-treat analysis? 
Yes 
Was there a between-group statistical comparison? 
Yes 
Does the study provide point measures and measures of variability for at least one 
key outcome? 
Yes 
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Study 4: Characteristics of study 
Author/s: Kass and Poeira, 2015 
Design Randomised, double-blind, placebo-controlled, cross-over trial 
Participants 
13 subjects, (7 males, 6 females), (mean ± SD age: 38.3 ± 5.3 years) 
recruited from recreational running, cycling and triathlete clubs, (45 ml/kg 
< VO₂ max for males; 35 ml/kg < VO₂ max for females) 
Dietary assessment 
(magnesium mg/day) 
4-day weighed food and beverage diary, including 3 weekdays and 1 
weekend day (mean ± SD magnesium intake at baseline; 375 ± 104 in 
chronic treatment, 368 ± 173 in acute treatment, 551 ± 347 in chronic 
placebo control, 378 ± 79 acute placebo control (all groups had intakes 
above RDA for magnesium) 
Magnesium status Not taken 
Intervention 
Acute (1 week) 75mg four times daily (300 mg/day) magnesium citrate, or 
Chronic (4 weeks) 75mg four times daily (300 mg/day) magnesium citrate 
on non-testing days or 300 mg magnesium citrate 3 hours before exercise 
testing 
Comparator 
1 week washout period followed by a cross-over. Cornflour was used as a 
placebo. 
Training regimen Not reported 
Outcomes of interest 1-RM bench press measured through 5-RM 
 
Study 4: Risk of bias assessment 
Item Answer 
Were eligibility criteria specified? 
Yes 
Were subjects randomly allocated to groups? 
Yes 
Was allocation concealed? 
Don't 
know 
Were groups similar at baseline for the most prognostic indicators? 
Yes 
Was there blinding of all subjects? 
Yes 
Was there blinding of all therapists? 
Yes 
Was there blinding of all assessors? 
Yes 
Were measures of at least one key outcome available for over 85% of initial 
subjects? 
Yes 
Was there an intention-to-treat analysis? 
No 
Was there a between-group statistical comparison? 
Yes 
Does the study provide point measures and measures of variability for at least one 
key outcome? 
Yes 
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Study 5: Characteristics of study 
Author/s: Kass, Skinner and Poeira, 2013 
Design Randomised, controlled, trial 
Participants 
16 males, 19-24 years old, > 4 hours/week aerobic exercise at >13 Borg Rating of 
Perceived Exertion Scale (RPE), normotensive (110/70 mmHg - 135/85 mmHg) 
Dietary assessment 
(magnesium mg/day) 
3-day dietary recall to assess habitual magnesium intake 
Magnesium status Not taken 
Intervention 150 mg twice daily (300 mg/day) magnesium oxide for 14 days 
Comparator No supplementation 
Training regimen > 4 hours/week aerobic exercise at > 13 Borg RPE 
Outcomes of interest 
mean of 3, 5-second maximal isometric bench press on a Marcy Smith Machine 
Plus measured by a Digital Analyser Isometric Transducer 
 
Study 5: Risk of bias assessment 
Item Answer 
Were eligibility criteria specified? 
Yes 
Were subjects randomly allocated to groups? 
Yes 
Was allocation concealed? 
Don't 
know 
Were groups similar at baseline for the most prognostic indicators? 
Yes 
Was there blinding of all subjects? 
No 
Was there blinding of all therapists? 
No 
Was there blinding of all assessors? 
Don't 
know 
Were measures of at least one key outcome available for over 85% of initial 
subjects? 
Yes 
Was there an intention-to-treat analysis? 
Yes 
Was there a between-group statistical comparison? 
Yes 
Does the study provide point measures and measures of variability for at least one 
key outcome? 
Yes 
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Study 6: Characteristics of study 
Author/s: Veronese et al., 2014 
Design Randomised Controlled Trial 
Participants 
139 healthy women, > 65 years (mean ± SD age: 71.5 ± 5.2 years) attending  a 
mild fitness program 
Dietary assessment 
(magnesium mg/day) 
Estimated 3 day record and food frequency questionnaire (not reported but stated 
that 24 participants in intervention and 30 in control group had below RDA intakes 
of Mg (p = 0.86) 
Magnesium status 
Serum magnesium (mmol/L); mean ± SD: 0.83 ± 0.04 in intervention and 0.84 ± 
0.06 in control at baseline. Increase observed at 12 weeks (0.009 ± 0.04 in control 
and 0.03 ± 0.04 in treated) 
Intervention 300 mg/day, magnesium oxide for 12 weeks 
Comparator no placebo 
Training regimen twice weekly mild fitness program 
Outcomes of interest 
Taken at baseline and at 12 weeks: Isometric knee extension torque (Nm) and 
isokinetic knee flexion and extension (Nm) using Easytech dynamometer chair, 
highest peak torque out of 3, for each. Handgrip (kg) measured with DynEx hand 
dynamometer, highest of 3. Body composition using Hologic Discovery A, DXA 
scan with fan-beam technology 
 
Study 6: Risk of bias assessment 
Item Answer 
Were eligibility criteria specified? 
Yes 
Were subjects randomly allocated to groups? 
Yes 
Was allocation concealed? 
Yes 
Were groups similar at baseline for the most prognostic indicators? 
Yes 
Was there blinding of all subjects? 
No 
Was there blinding of all therapists? 
Yes 
Was there blinding of all assessors? 
Yes 
Were measures of at least one key outcome available for over 85% of initial subjects? 
Yes 
Was there an intention-to-treat analysis? 
Yes 
Was there a between-group statistical comparison? 
Yes 
Does the study provide point measures and measures of variability for at least one 
key outcome? 
Yes 
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Study 7: Characteristics of study 
Author/s: Gullestad et al., 1992 
Design Randomised, double-blind, placebo-controlled, trial 
Participants 
52 (17 females and 35 males) chronic (> 10 years) alcoholics, mean age: 57 
years, serum creatinine < 150 µmol/L, no cardiac A-V disturbances and no 
previous Mg supplementation, hepatitis A and B negative. 
Dietary assessment 
(mg/day) 
None but all participants were told to minimise alcohol consumption and avoid 
magnesium rich foods 
Magnesium status 
Serum magnesium (mmol/L); mean ± SD: 0.86 ± 0.12 in intervention and 0.84 ± 
0.15 in control, at baseline. Change after 6 weeks: 0.02 ± 0.02 in treated and -
0.05 ± 0.03 in control 
Intervention 
125 mg three times daily (375 mg/day) magnesium lactate-citrate for 6 weeks 
Comparator matched placebo 
Training regimen None 
Outcomes of interest 
Handgrip strength (bar) measured with a Martin strain-gauge dynamometer, 
highest of 3 readings.  
 
Study 7: Risk of bias assessment 
Item Answer 
Were eligibility criteria specified? 
Yes 
Were subjects randomly allocated to groups? 
Yes 
Was allocation concealed? 
Don't 
know 
Were groups similar at baseline for the most prognostic indicators? 
Yes 
Was there blinding of all subjects? 
Yes 
Was there blinding of all therapists? 
Yes 
Was there blinding of all assessors? 
Yes 
Were measures of at least one key outcome available for over 85% of initial 
subjects? 
Yes 
Was there an intention-to-treat analysis? 
No 
Was there a between-group statistical comparison? 
Yes 
Does the study provide point measures and measures of variability for at least one 
key outcome? 
Yes 
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Study 8: Characteristics of study 
Author/s: Aagaard et al., 2005 
Design Randomised, placebo-controlled trial 
Participants 
59 patients (49 males, 10 females), age range: (34-61) with alcoholic liver disease 
and mean daily alcohol consumption of 187 g/day for more than 5 years. 
Dietary assessment 
(magnesium mg/day) 
Not measured 
Magnesium status 
Muscle magnesium (µmol/g wet weight), reported instead.  After 7 weeks; 
increased by 7% in treatment group 
Intervention 
728 mg intravenous magnesium sulphate diluted in 1litre 5% glucose solution on 
days 1 and 2 followed by 7 weeks of 150 mg twice daily (300 mg/day) magnesium 
oxide 
Comparator 
1L of 5% glucose solution on days 1 and 2 followed by 7 weeks of a mixture of 
lactulose, gelatine and stearate 
Training regimen None required 
Outcomes of interest 
Isokinetic knee extension strength (Nm) measured with Lido Active Muscle Joint 
dynamometer, largest peak torque of 8. Muscle mass (kg) determined through 24-
hour urinary creatinine excretion. 
 
Study 8: Risk of bias assessment 
Item Answer 
Were eligibility criteria specified? 
Yes 
Were subjects randomly allocated to groups? 
Yes 
Was allocation concealed? 
Yes 
Were groups similar at baseline for the most prognostic indicators? 
Yes 
Was there blinding of all subjects? 
Yes 
Was there blinding of all therapists? 
Don't 
know 
Was there blinding of all assessors? 
Don't 
know 
Were measures of at least one key outcome available for over 85% of initial 
subjects? 
Yes 
Was there an intention-to-treat analysis? 
Don't 
know 
Was there a between-group statistical comparison? 
Yes 
Does the study provide point measures and measures of variability for at least one 
key outcome? 
Yes 
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Study 9: Characteristics of study 
Author/s: Poikolainen and Alho, 2008 
Design Randomised, double-blind, placebo-controlled, trial 
Participants 
118 participants (81 males, 37 females), 20-64 years ( mean ± SD age: 
45.3 ± 10 years) with acute alcohol withdrawal symptoms or elevated 
Serum Gamma-Glutamyltransferase, < 10 tablets of 250mg Mg over the 
previous 2 months, no history of heart rhytm disturbances, Mg not 
contraindicated, normal serum creatinine 
Dietary assessment 
(magnesium mg/day) 
Not measured 
Magnesium status 
Serum magnesium (mmol/L):Taken at baseline and at 8 weeks, only 
changes reported (mean ± SD: 0.06 ± 0.12 in treated and 0.01 ± 0.08 in 
placebo) 
Intervention 
8 weeks of 250mg twice daily magnesium (500 mg/day), consisting of a 
mixture of magnesium carbonate, acetate and hydroxide 
Comparator matched placebo 
Training regimen None 
Outcomes of interest 
Maximal handgrip strength measured in sitting position with Martin strain-
gauge dynamometer, mean of three measurements 
 
Study 9: Risk of bias assessment 
Item Answer 
Were eligibility criteria specified? 
Yes 
Were subjects randomly allocated to groups? 
Yes 
Was allocation concealed? 
Don't 
know 
Were groups similar at baseline for the most prognostic indicators? 
Don't 
know 
Was there blinding of all subjects? 
Yes 
Was there blinding of all therapists? 
Yes 
Was there blinding of all assessors? 
Yes 
Were measures of at least one key outcome available for over 85% of initial 
subjects? 
No 
Was there an intention-to-treat analysis? 
Yes 
Was there a between-group statistical comparison? 
Yes 
Does the study provide point measures and measures of variability for at least one 
key outcome? 
Yes 
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Table 1: Effects of Magnesium Supplementation on Strength 
Author PEDro 
Score/ 
10 
Subjects 
(n) and 
age 
Health 
status 
Dietary Mg 
intake at 
baseline 
Changes in 
Magnesium 
status 
Treatment 
details 
Mg 
supplement 
Duration Physical 
activity 
Compliance 
to 
treatment 
Outcome/s 
considered 
Treatment 
effect 
Moslehi, 
Vafa, 
Sarraf-
zadeh & 
Foroush
ani 
(2013) 
8 
74 
females, 
aged 40-
55 years 
Overweight 
but healthy 
156.05 ± 
60.15 
mg/day 
No changes 
reported 
after 8 
weeks 
250 mg/day MgO 8 weeks 
No 
significant 
changes in 
mean 
physical 
activity 
93% 
Handgrip 
strength 
and 
Isometric 
knee 
extension 
No significant 
differences 
Brilla & 
Haley 
(1992) 
8 
26 
subjects, 
aged 18-
30 
Untrained 
Mean of 246 
mg/day 
Not 
measured 
Total of dietary 
and 
supplemented  
8 mg/kg 
bodyweight/day 
(Around 271 
mg/day) 
MgO 7 weeks 
3 X 10 
repetitions 
leg press 
and leg 
extension, 3 
times per 
week 
Not 
measured 
Isokinetic 
knee 
extension 
strength 
Mg 
supplemented 
gained more 
strength (p < 
0.05) 
Setaro 
et al. 
(2014) 
9 
25 
males, 
aged 15-
20 
Healthy 
Not 
measured 
Plasma Mg 
decreased 
more in 
treatment 
arm 
350 mg/day MgO 4 weeks 
6 hours 
professional 
volleyball 
off-season 
training/day 
Not 
measured 
Isokinetic 
knee flexion 
and 
extension  
Both groups 
gained 
strength. No 
significant 
difference 
between 
groups 
Kass & 
Poeira 
(2015) 
8 
13 
subjects 
(7 males, 
6 
females), 
mean 
age: 38.3 
years 
Healthy 
All groups > 
350 mg/day. 
Chronic 
placebo 
group > 550 
mg/day 
Not 
measured 
300 mg/day 
Magnesium 
citrate 
Acute (1 
week); 
Chronic 
(4 
weeks) 
Recreational 
runners, 
cyclists and 
triathletes 
Not 
measured 
1-RM 
bench 
press 
Strength 
increase in 
acute 
intervention 
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Table 1: Effects of Magnesium Supplementation on Strength (Continued [1]) 
Author PEDro 
Score/10 
Subjects 
(n) and 
age 
Health 
status 
Dietary Mg 
intake at 
baseline 
Changes in 
Magnesium 
status 
Treatment 
details 
Mg 
supplement 
Duration Physical 
activity 
Compliance 
to 
treatment 
Outcome/s 
considered 
Treatment 
effect 
Kass, 
Skinner & 
Poeira 
(2013) 
6 
16 
males, 
aged 19-
24 
Healthy 
6 subjects < 
300 mg/day; 
10 subjects 
> 300 
mg/day 
Not measured 
300 
mg/day 
MgO 2 weeks 
>4 
hours/week 
aerobic 
exercise 
Not 
measured 
5 second 
maximal 
isometric 
bench 
press 
contraction 
No 
significant 
differences 
Veronese 
et al. 
(2014) 
9 
139 
women, 
aged >65 
years 
Healthy 
24 in 
intervention, 
30 in control 
had < 320 
mg of 
Mg/day 
Serum Mg 
increased in 
intervention 
group 
300 
mg/day 
MgO 
12 
weeks 
Mild fitness 
program 
85-95% 
Isometric 
knee 
extension. 
Isokinetic 
knee 
extension 
and flexion. 
Handgrip 
strength. 
Both 
groups 
gained 
strength. 
No 
difference 
significant 
between 
groups 
Gullestad 
et al. 
(1992) 
8 
52 (17 
females, 
35 
males), 
mean 
age: 57 
years 
Chronic (> 
10 years) 
alcoholics 
Participants 
advised to 
reduce 
alcohol and 
magnesium-
rich foods 
Serum Mg 
increased 
slightly in 
treated and 
decreased in 
control 
375 
mg/day 
Magnesium 
lactate-
citrate 
6 weeks 
None 
specified 
Not 
measured 
Handgrip 
strength 
Increased 
significantly 
in 
intervention 
group 
Aagard et 
al. (2005) 
7 
59 
patients 
(49 
males, 
10 
females), 
aged 34-
61 years 
Alcoholic 
liver 
disease. 
Mean 
daily 
alcohol 
168g/day 
for > 5 
years 
Not 
measured 
Muscle Mg 
increased 7% 
in intervention 
728 
mg/day IV 
Mg for 2 
days and 7 
weeks 
300mg/day 
oral Mg 
IV MgSO₄ 
and oral 
MgO 
7 weeks 
None 
specified 
16 dropouts 
Isokinetic 
knee 
extension 
Both 
groups 
gained 
strength. 
No 
significant 
difference 
between 
groups 
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Table 1: Effects of Magnesium Supplementation on Strength (Continued [2]) 
 
 
 
 
Author PEDro 
Score/10 
Subjects 
(n) and 
age 
Health 
status 
Dietary Mg 
intake at 
baseline 
Changes in 
Magnesium 
status 
Treatment 
details 
Mg 
supplement 
Duration Physical 
activity 
Compliance 
to 
treatment 
Outcome/s 
considered 
Treatment 
effect 
Poikolainen 
& Alho 
(2008) 
7 
118 
subjects 
(81 
males, 
37 
females), 
aged 20-
64 years 
Acute 
alcohol 
withdrawal 
symptoms. 
Elevated 
S-GGT 
Not 
measured 
Serum Mg; 
increased in 
both groups 
but more in 
supplemented 
500 
mg/day 
Mixture of 
magnesium 
carbonate, 
acetate and 
hydroxide 
8 weeks 
None 
specified 
83.40% 
Handgrip 
strength 
No 
significant 
differences 
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Table 2: Effects of Magnesium Supplementation on Body Composition 
Author PEDro 
Score 
/10 
Subjects 
(n) and 
age 
Health 
status 
Dietary Mg 
intake at 
baseline 
Changes in 
Magnesium 
status 
Treatment 
details 
Mg 
supplement 
Duration Physical 
activity 
Compliance 
to treatment 
Body 
composition 
outcomes 
Treatment 
effect 
Moslehi, 
Vafa, 
Sarrafzad
eh & 
Forousha
ni (2013) 
8 
74 
females, 
aged 40-
55 years 
Overweight 
but healthy 
 
 
156.05 ± 
60.15 
mg/day 
 
No changes 
reported 
after 8 
weeks 
250 mg/day MgO 8 weeks 
No 
significant 
changes 
in mean 
physical 
activity 
93% 
Lean Body 
Mass and 
Fat Mass 
(BIA) 
Increase in 
lean body 
mass and 
reduction in 
fat mass 
Brilla & 
Haley 
(1992) 
8 
26 
subjects, 
aged 18-
30 
Untrained 
 
 
 
Mean of 
246 mg/day 
 
Not 
measured 
Total of 
dietary and 
supplemented 
Mg 8 mg/kg 
bodyweight/d
ay (Around 
271 mg/day)  
MgO 7 weeks 
3 X 10 
repetitions 
leg press 
and leg 
extension, 
3 times 
per week 
Not 
measured 
Lean Body 
Mass and 
Fat Mass 
(BIA) 
No 
significant 
differences 
Veronese 
et al. 
(2014) 
9 
139 
women, 
aged >65 
years 
Healthy 
24 in 
intervention
, 30 in 
control had 
intakes < 
320 mg of 
Mg/day 
Serum Mg 
significantly 
increased in 
intervention 
group 
300 mg/day MgO 12 weeks 
Mild 
fitness 
program 
85-95% 
Fat-free 
mass and 
Fat Mass 
(DXA scan) 
No 
significant 
differences 
Aagard et 
al. (2005) 
7 
59 
patients 
(49 males, 
10 
females), 
aged 34-
61 years 
Alcoholic 
liver 
disease. 
Mean daily 
alcohol 
168g/day 
for > 5 
years 
 
 
Not 
measured 
 
Muscle Mg 
increased 
7% in 
intervention 
728 mg/day 
IV Mg for 2 
days and 7 
weeks 
300mg/day 
oral Mg 
IV MgSO₄ 
and oral 
MgO 
7 weeks 
None 
specified 
16 dropouts 
Muscle 
mass (24-
hour urinary 
creatinine 
excretion) 
 
 
Both 
groups 
gained 
muscle 
mass. No 
significant 
difference 
between 
groups 
 
